Polio eradication in the World Health Organization African Region, 2008-2012.

A renewed commitment at the regional and the global levels led to substantial progress in the fight for polio eradication in the African Region (AFR) of the World Health Organization (WHO) during 2008-2012. In 2008, there were 912 reported cases of wild poliovirus (WPV) infection in 12 countries in the region. This number had been reduced to 128 cases in 3 countries in 2012, of which 122 were in Nigeria, the only remaining country with endemic circulation of WPV in AFR. During 2008-2012, circulation apparently ceased in the 3 AFR countries with reestablished WPV transmission-Angola, the Democratic Republic of the Congo, and Chad. Outbreaks in West Africa continued to occur in 2008-2010 but were more rapidly contained, with fewer cases than during earlier years. This progress has been attributed to better implementation of core strategies, increased accountability, and implementation of innovative approaches. During this period, routine coverage with 3 doses of oral polio vaccine in AFR, as measured by WHO-United Nations Children's Fund estimates, increased slightly, from 72% to 74%. Despite this progress, challenges persist in AFR, and 2013 was marked by new setbacks and importations. High population immunity and strong surveillance are essential to sustain progress and assure that AFR reaches its goal of eradicating WPV.

[1]  J. Qazi,et al.  From Pakistan a line of hope for ‘The Polio Eradication and Endgame Strategic Plan 2013–2018’ , 2016, Infectious diseases.

[2]  Hiromasa Okayasu,et al.  Cluster lot quality assurance sampling: effect of increasing the number of clusters on classification precision and operational feasibility. , 2014, The Journal of infectious diseases.

[3]  Sarah A. Meyer,et al.  Improved acute flaccid paralysis surveillance performance in the Democratic Republic of the Congo, 2010-2012. , 2014, The Journal of infectious diseases.

[4]  O. Kew,et al.  Update on Vaccine-Derived Polioviruses — Worldwide, July 2012–December 2013 , 2014, MMWR. Morbidity and mortality weekly report.

[5]  F. Mahoney,et al.  Progress Toward Poliomyelitis Eradication — Nigeria, January 2012–September 2013 , 2013, MMWR. Morbidity and mortality weekly report.

[6]  B. Schoub Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa. , 2012, Vaccine.

[7]  M. Pallansch,et al.  An outbreak of wild poliovirus in the Republic of Congo, 2010-2011. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Roivainen,et al.  Role of environmental poliovirus surveillance in global polio eradication and beyond , 2011, Epidemiology and Infection.

[9]  K. Greenland,et al.  Clustered lot quality assurance sampling: a pragmatic tool for timely assessment of vaccination coverage , 2011, Tropical medicine & international health : TM & IH.

[10]  K. Wannemuehler,et al.  Poliomyelitis outbreaks in Angola genetically linked to India: risk factors and implications for prevention of outbreaks due to wild poliovirus importations. , 2011, Vaccine.

[11]  M. Pate,et al.  Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population , 2011, The Journal of infectious diseases.

[12]  Poliomyelitis outbreak--Republic of the Congo, September 2010-February 2011. , 2011, MMWR. Morbidity and mortality weekly report.

[13]  G. I. Div Wild poliovirus type 1 and type 3 importations - 15 countries, Africa, 2008-2009. , 2009 .